68
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.

      Science (New York, N.Y.)
      Antibodies, Viral, blood, Epitopes, B-Lymphocyte, genetics, immunology, High-Throughput Nucleotide Sequencing, methods, Host-Pathogen Interactions, Humans, Immune System, virology, Immunoprecipitation, Peptide Library, Serologic Tests, Virus Diseases, diagnosis, Viruses

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The human virome plays important roles in health and immunity. However, current methods for detecting viral infections and antiviral responses have limited throughput and coverage. Here, we present VirScan, a high-throughput method to comprehensively analyze antiviral antibodies using immunoprecipitation and massively parallel DNA sequencing of a bacteriophage library displaying proteome-wide peptides from all human viruses. We assayed over 10(8) antibody-peptide interactions in 569 humans across four continents, nearly doubling the number of previously established viral epitopes. We detected antibodies to an average of 10 viral species per person and 84 species in at least two individuals. Although rates of specific virus exposure were heterogeneous across populations, antibody responses targeted strongly conserved "public epitopes" for each virus, suggesting that they may elicit highly similar antibodies. VirScan is a powerful approach for studying interactions between the virome and the immune system. Copyright © 2015, American Association for the Advancement of Science.

          Related collections

          Author and article information

          Comments

          Comment on this article